Uploaded February 2026 | Updated September 2026, 2 weeks ago
In today’s episode, David Meltzer talks with Sarah Kennedy, founder and CEO of Calocurb, about a plant based approach to appetite management built on years of research in New Zealand. They break down how her capsule works in the upper intestine to stimulate the body’s own appetite suppressing hormones, why that differs from synthetic GLP 1 drugs, and what the clinical results show around hunger, cravings, and calorie intake. They also talk about the myth of willpower, how the hind brain drives eating behavior, and why coming off injectable solutions can trigger intense rebound hunger.
►Subscribe to My Channel: youtube.com/channel/UCagv831FLtWPFx-5yY2Styw?sub_confirmation=1
►Text Me! (949) 298-2905
►Email me at David@dmeltzer.com
►Subscribe to My Podcast: hoo.be/davidmeltzer
In today’s episode, David Meltzer talks with Sarah Kennedy, founder and CEO of Calocurb, about a plant based approach to appetite management built on years of research in New Zealand. They break down how her capsule works in the upper intestine to stimulate the body’s own appetite suppressing hormones, why that differs from synthetic GLP 1 drugs, and what the clinical results show around hunger, cravings, and calorie intake. They also talk about the myth of willpower, how the hind brain drives eating behavior, and why coming off injectable solutions can trigger intense rebound hunger.
►Subscribe to My Channel: youtube.com/channel/UCagv831FLtWPFx-5yY2Styw?sub_confirmation=1
►Text Me! (949) 298-2905
►Email me at David@dmeltzer.com
►Subscribe to My Podcast: hoo.be/davidmeltzer










